These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 1360759

  • 1. Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect.
    Otová B, Votruba I, Holý A.
    Acta Virol; 1992 May; 36(3):313-9. PubMed ID: 1360759
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
    Neyts J, Snoeck R, Schols D, Balzarini J, De Clercq E.
    Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P, Connelly MC, Srinivas RV, Fridland A.
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication.
    Snoeck R, Sakuma T, De Clercq E, Rosenberg I, Holy A.
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1839-44. PubMed ID: 2854454
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir.
    Gordon YJ, Araullo-Cruz TP, Johnson YF, Romanowski EG, Kinchington PR.
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2774-8. PubMed ID: 8977495
    [Abstract] [Full Text] [Related]

  • 15. Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine on the replication and morphogenesis of herpes simplex virus type 1.
    Chatterjee S, Burns P, Whitley RJ, Kern ER.
    Antiviral Res; 1992 Sep; 19(3):181-92. PubMed ID: 1332603
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors.
    Bedard J, May S, Barbeau D, Yuen L, Rando RF, Bowlin TL.
    Antiviral Res; 1999 Feb; 41(1):35-43. PubMed ID: 10321577
    [Abstract] [Full Text] [Related]

  • 18. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
    Gordon YJ, Romanowski EG, Araullo-Cruz T.
    Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.